Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)

OJ Storebø, MRO Storm, JP Ribeiro… - Cochrane Database …, 2023 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly
diagnosed and treated psychiatric disorders in childhood. Typically, children and …

Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents–assessment of adverse events in non‐randomised studies

OJ Storebø, N Pedersen, E Ramstad… - Cochrane Database …, 2018 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity

M Huss, P Duhan, P Gandhi, CW Chen… - Neuropsychiatric …, 2017 - Taylor & Francis
Attention-deficit/hyperactivity disorder (ADHD) is a chronic psychiatric disorder characterized
by hyperactivity and/or inattention and is often associated with a substantial impact on …

Sleep as an outcome measure in ADHD randomized controlled trials: a scoping review

S McWilliams, T Zhou, S Stockler, D Elbe… - Sleep Medicine …, 2022 - Elsevier
Sleep disturbances are highly prevalent among children with ADHD. Yet, diagnostic and
treatment regimens are primarily focused on daytime symptomatology. The goals of this …

New formulations of stimulants: an update for clinicians

R Steingard, S Taskiran, DF Connor… - Journal of child and …, 2019 - liebertpub.com
In the last 15 years, there has been a marked increase in the number of available stimulant
formulations with the emphasis on long-acting formulations, and the introduction of several …

Evaluation of methylphenidate safety and maximum-dose titration rationale in attention-deficit/hyperactivity disorder: a meta-analysis

C Ching, GD Eslick, AS Poulton - JAMA pediatrics, 2019 - jamanetwork.com
Importance Evidence on the titration of stimulant medications for attention-
deficit/hyperactivity disorder (ADHD) is lacking. However, this lack of evidence has not …

[HTML][HTML] Sleep-associated adverse events during methylphenidate treatment of attention-deficit/hyperactivity disorder: A meta-analysis

SV Faraone, MD Po, M Komolova… - The Journal of clinical …, 2019 - psychiatrist.com
Objective: Sleep disturbances are a feature of attention-deficit/hyperactivity disorder (ADHD)
and an adverse event (AE) of methylphenidate treatment. The authors sought to clarify …

Safety profile of methylphenidate under long-term treatment in adult ADHD patients–results of the COMPAS study

B Kis, C Lücke, M Abdel-Hamid, P Heßmann… - …, 2020 - thieme-connect.com
Introduction The Comparison of Methylphenidate and Psychotherapy in adult ADHD Study
(COMPAS) was a prospective, randomized multicenter clinical trial, comparing …

An evaluation on the efficacy and safety of treatments for attention deficit hyperactivity disorder in children and adolescents: a comparison of multiple treatments

Y Li, J Gao, S He, Y Zhang, Q Wang - Molecular neurobiology, 2017 - Springer
Attention deficit hyperactivity disorder (ADHD) is one of the most common neurobehavioral
disorders. We carried out this comparison of multiple treatments based on sufficient data in …

Changes in behavior as side effects in methylphenidate treatment: review of the literature

DS Konrad-Bindl, U Gresser… - … disease and treatment, 2016 - Taylor & Francis
Background Our review of the scientific literature focused on an analysis of studies
describing instances of methylphenidate treatment leading (or not) to behavioral changes in …